Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...

Full description

Saved in:
Bibliographic Details
Published in:J Med Case Rep
Main Authors: Dao, Abou, Benchakroun, Nadia, Jabir, Hamza, Taleb, Amina, Bouchbika, Zineb, Tawfiq, Nezha, Jouhadi, Hassan, Sahraoui, Souha, Benider, Abdellatif
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/
https://ncbi.nlm.nih.gov/pubmed/25488584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items